ATE375141T1 - Verfahren und mittel zur behandlung und vorbeugung von erkrankungen der hinteren augenkammer - Google Patents

Verfahren und mittel zur behandlung und vorbeugung von erkrankungen der hinteren augenkammer

Info

Publication number
ATE375141T1
ATE375141T1 AT01914710T AT01914710T ATE375141T1 AT E375141 T1 ATE375141 T1 AT E375141T1 AT 01914710 T AT01914710 T AT 01914710T AT 01914710 T AT01914710 T AT 01914710T AT E375141 T1 ATE375141 T1 AT E375141T1
Authority
AT
Austria
Prior art keywords
eye
compositions
treating
preventing diseases
posterior chamber
Prior art date
Application number
AT01914710T
Other languages
English (en)
Inventor
Erwin Si
Lyle Bowman
Cheryl Rowe-Rendleman
Samir Roy
Original Assignee
Insite Vision Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/523,102 external-priority patent/US7141607B1/en
Application filed by Insite Vision Inc filed Critical Insite Vision Inc
Application granted granted Critical
Publication of ATE375141T1 publication Critical patent/ATE375141T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT01914710T 2000-03-10 2001-03-07 Verfahren und mittel zur behandlung und vorbeugung von erkrankungen der hinteren augenkammer ATE375141T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/523,102 US7141607B1 (en) 2000-03-10 2000-03-10 Methods and compositions for treating and inhibiting retinal neovascularization
US64844600A 2000-08-28 2000-08-28

Publications (1)

Publication Number Publication Date
ATE375141T1 true ATE375141T1 (de) 2007-10-15

Family

ID=27061037

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01914710T ATE375141T1 (de) 2000-03-10 2001-03-07 Verfahren und mittel zur behandlung und vorbeugung von erkrankungen der hinteren augenkammer

Country Status (9)

Country Link
EP (2) EP1261317B1 (de)
JP (1) JP2003529567A (de)
KR (1) KR20010113918A (de)
AT (1) ATE375141T1 (de)
AU (1) AU785285B2 (de)
CA (1) CA2373237A1 (de)
DE (1) DE60130872T2 (de)
MX (1) MXPA01011346A (de)
WO (1) WO2001068053A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102294023A (zh) * 2001-07-26 2011-12-28 奥塔戈创新公司 抗原组合物
HRP20040406A2 (en) * 2001-11-09 2005-02-28 Eyetech Pharmaceuticals Methods for treating ocular neovascular diseases
US20060281821A1 (en) * 2003-03-14 2006-12-14 Krzysztof Palczewski Retinoid replacements and opsin agonists and methods for the use thereof
EP1720555A1 (de) * 2004-02-26 2006-11-15 Advanced Ocular Systems Limited Tetracyclin-derivate zur behandlung von augenerkrankungen
AU2005257997B2 (en) 2004-06-18 2012-04-05 University Of Washington Retinal derivatives and methods for the use thereof for the treatment of visual disorders
CA2595400C (en) 2005-01-20 2017-01-17 Institute For Molecular Medicine, Inc. Methylphenidate derivatives and their use in the treatment of angiogenic diseases and conditions
EP2462959B1 (de) 2005-07-12 2016-06-22 Ampio Pharmaceuticals, Inc. Verfahren und Produkte zur Behandlung von Erkrankungen
RU2542471C2 (ru) 2006-11-15 2015-02-20 Коуда Терапьютикс, Инк. Улучшенные способы и композиции для заживления ран
JP5856843B2 (ja) 2008-05-27 2016-02-10 アンピオ ファーマシューティカルズ，インコーポレイテッド ジケトピペラジンを用いた医薬組成物
US8501800B2 (en) * 2009-03-05 2013-08-06 Insite Vision Incorporated Controlled-release ophthalmic vehicles
SG2014008171A (en) 2009-06-22 2014-04-28 Ampio Pharmaceuticals Inc Method for treatment of diseases
EP2613786A4 (de) 2010-09-07 2013-10-23 Dmi Acquisition Corp Behandlung von erkrankungen
US20140045951A1 (en) * 2011-04-27 2014-02-13 Osaka University Synthetic vitreous material
US9694050B2 (en) 2012-10-21 2017-07-04 University Of Rochester THY1 (CD90) as a novel therapy to control adipose tissue accumulation
SG11201504380SA (en) 2012-12-19 2015-07-30 Ampio Pharmaceuticals Inc Method for treatment of diseases
WO2016029191A2 (en) 2014-08-22 2016-02-25 Auckland Uniservices Limited Channel modulators
US11524053B2 (en) 2018-01-26 2022-12-13 The Regents Of The University Of California Methods and compositions for treatment of angiogenic disorders using anti-VEGF agents
WO2020171889A1 (en) 2019-02-19 2020-08-27 University Of Rochester Blocking lipid accumulation or inflammation in thyroid eye disease
CN114867487A (zh) 2019-11-25 2022-08-05 加利福尼亚大学董事会 用于眼内新生血管的长效vegf抑制剂
US12667586B2 (en) 2023-03-07 2026-06-30 Glaukos Corporation Treatments for ocular surface disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ226171A (en) * 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor
CA2150554A1 (en) * 1992-12-02 1994-06-09 Sheng-Wan Tsao Cyclodextrin and polymer based drug delivery system
US5652209A (en) * 1994-04-29 1997-07-29 University Of Miami Use of secretory products of human lacrimal gland acinar epithelia for tear replacement therapy
US5431907A (en) * 1994-08-03 1995-07-11 Abelson; Mark B. Treatment of vascular disorders of the posterior segment of the eye by topical administration of calcium channel blocking agents
AU2438297A (en) * 1996-05-09 1997-11-26 Alcon Laboratories, Inc. Combinations of angiostatic compounds
US6066675A (en) * 1996-09-13 2000-05-23 The Regents Of The University Of California Method for treatment of retinal diseases
JPH1180024A (ja) * 1997-09-12 1999-03-23 Toagosei Co Ltd 角膜血管新生阻害剤
US5948801A (en) * 1998-03-09 1999-09-07 Alcon Laboratories, Inc. Treatment of retinal edema with brinzolamide
US6378526B1 (en) * 1998-08-03 2002-04-30 Insite Vision, Incorporated Methods of ophthalmic administration
EP1040837A3 (de) * 1999-02-26 2002-01-02 Erasmus Universiteit Rotterdam Medikamente zur Behandlung von Erkrankungen der Aderhaut des Auges

Also Published As

Publication number Publication date
EP1261317B1 (de) 2007-10-10
CA2373237A1 (en) 2001-09-20
MXPA01011346A (es) 2002-09-02
AU4006601A (en) 2001-09-24
JP2003529567A (ja) 2003-10-07
AU785285B2 (en) 2006-12-21
DE60130872D1 (de) 2007-11-22
DE60130872T2 (de) 2008-07-17
EP1938799A1 (de) 2008-07-02
KR20010113918A (ko) 2001-12-28
WO2001068053A3 (en) 2002-08-29
WO2001068053A2 (en) 2001-09-20
EP1938799B1 (de) 2013-05-08
EP1261317A2 (de) 2002-12-04

Similar Documents

Publication Publication Date Title
DE60130872D1 (de) Verfahren und mittel zur behandlung und vorbeugung von erkrankungen der hinteren augenkammer
DE60027431D1 (de) Verwendung von p38 MAPK Inhibitoren in der Behandlung von Augenkrankheiten
DE60138137D1 (de) Verfahren und zusammensetzungen zur behandlung von okularer neovaskularisierung und nervenverletzungen
ATE362363T1 (de) Verwendung von tnf-alpha inhibitoren zur behandlung von nervenwurzelschäden
DE60227658D1 (de) Verfahren zur behandlung neurodegenerativer, psychiatrischer und anderer störungen mit deacetylaseinhibitoren
TW200633709A (en) Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases and conditions
ATE478669T1 (de) Zusammenstellungen und methoden zur behandlung der alzheimerschen krankheit, schäden des zentralnervensystems und entzündlichen erkrankungen
ATE254461T1 (de) Behandlung von augenschmerzen
ATE221781T1 (de) Angiostatische verbindungen und zusammensetzungen zur behandlung des glc1a glaukoms
ATE260653T1 (de) Verwendung von naaladase inhibitoren zur behandlung von angstzuständen und gedächtnisstörungen
ATE435026T1 (de) Verfahren zur prävention und behandlung von diabetes mit neurturin
MXPA05008561A (es) Uso de esteroides para tratar personas que sufren de trastornos oculares.
EP4511369A4 (de) Indolinderivate als serotonergische mittel zur behandlung von damit in zusammenhang stehenden erkrankungen
NO20044530L (no) Fremgangsmate for behandling av kognitive forstyrrelser
DE60136748D1 (de) Verfahren und zusammensetzungen zur behandlung von augenerkrankungen
DE60218153D1 (de) Verwendung von proteasom-inhibitoren zur behandlung des trockenen auges
MXPA02011921A (es) Inhibidores de dipeptidasa acida n-acetilada-alfa-enlazada para el tratamiento de trastornos retinianos y glaucona.
ATE428470T1 (de) Heilmittel zur behandlung von erkrankungen des sehnervs
WO2023147513A3 (en) Compositions of autophagy modulating agents and uses thereof
ATE252387T1 (de) Verwendung von staurosporine derivaten zur behandlung von okularen neovaskularen erkrankungen
EP4326327A4 (de) Inhibitoren von ubiquitin-spezifischer peptidase 22 (usp22) und verwendungen davon zur behandlung von krankheiten und störungen
ATE513471T1 (de) Verfahren und zusammensetzungen zur behandlung von erkrankungen
ATE425967T1 (de) Piperazin und piperadin-derivate fur die behandlung von neurologischen krankheiten
ATE359774T1 (de) Taurinderivate verwendbar in der behandlung von netzhauterkrankungen
ATE448779T1 (de) Methode zur behandlung trockener augen und uveitis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties